In the present investigation, the necessary tests for implementing a quality assurance program for a commercial treatment planning system ͑TPS͒, recently installed at Sao Paulo University School of Medicine Clinicas Hospital-Brazil, was established and performed in accordance with the new IAEA publication TRS 430, and with AAPM Task Group 53. The tests recommended by those documents are classified mainly into acceptance, commissioning ͑dosimetric and nondosimetric͒, periodic quality assurance, and patient specific quality assurance tests. The recommendations of both IAEA and AAPM documents are being implemented at the hospital for photon beams produced by two linear accelerators. A Farmer ionization chamber was used in a 30ϫ 30ϫ 30 cm 3 phantom with a dose rate of 320 monitor unit ͑MU͒/min and 50 MU in the case of the dosimetric tests. The acceptance tests verified hardware, network systems integration, data transfer, and software parameters. The results obtained are in good agreement with the specifications of the manufacturer. For the commissioning dosimetric tests, the absolute dose was measured for simple geometries, such as square and rectangular fields, up to more complex geometries such as off-axis hard wedges and for behavior in the build up region. Results were analysed by the use of confidence limit as proposed by Venselaar et al. ͓Radio Ther. Oncol. 60, 191-201 ͑2001͔͒. Criteria of acceptability had been applied also for the comparison between the values of MU calculated manually and MU generated by TPS. The results of the dosimetric tests show that work can be reduced by choosing to perform only those that are more crucial, such as oblique incidence, shaped fields, hard wedges, and buildup region behavior. Staff experience with the implementation of the quality assurance program for a commercial TPS is extremely useful as part of a training program.
I. INTRODUCTION
At present, practically all radiotherapy services use some type of computerized treatment planning system ͑TPS͒, from the simplest two-dimensional ͑2-D͒ to the most sophisticated three-dimensional ͑3-D͒ Monte Carlo simulations, so that TPS has become an integral part of routine for physicists and physicians working in radiotherapy.
With the fast evolution of TPS, either in terms of use of more adequate algorithms that represent physical reality with more verisimilitude or by means of image visualization using very sophisticated graphic displays, radiotherapy professionals have had to quickly adapt to new techniques and procedures. Thus, it is mandatory that the implementation of a quality assurance program for the TPS shows practical and direct rules for the efficient training of system users, providing a refined knowledge of the TPS procedures, besides confirming that the system tasks are performed in accordance with specifications.
The global need of quality assurance of computers used in radiotherapy has already been discussed in the literature. [1] [2] [3] On the other hand, the specific requirements for quality assurance of the treatment planning systems has been less extensively described in a series of papers. [4] [5] [6] [7] [8] [9] [10] [11] The document of the American Association of Physicists in Medicine ͑AAPM͒ elaborated by the task group TG 53 12 established some parameters to be followed in the implementation of a quality assurance ͑QA͒ program for TPS, and the most recent document of the International Atomic Energy Agency ͑IAEA͒, TRS 430, 13 details the several tests to be performed inside a complete TPS quality assurance program.
The development of a quality assurance program for treatment planning systems in radiotherapy requires not only the commissioning of the TPS, but also needs the guarantee of the quality of the planning process as a whole. The main component of a quality assurance program consists of the creation of a process of treatment planning that incorporates auto-consistency as well as tests on the clinical procedures used in the hospital.
In the elaboration of a program of this type, it is important to consider all the steps of treatment planning, from the therapeutic decision of planning target volume localization, the selection of treatment technique, the determination of radiation beam direction, patient simulation, manufacture of auxiliary devices, monitor units calculations, up to the final treatment verification. For the present work, acceptance and commissioning of the Varian Eclipse™ 7.3.10 was per-formed, as well as definition of testing procedures for periodic control of external photon beams at the Clinicas Hospital.
In accordance with TRS 430, 13 the steps for the implementation of a program are: acceptance tests; commissioning ͓dosimetric, nondosimetric and calculation of monitor unit ͑MU͒ tests͔; periodic control and patient specific quality assurance.
Acceptance tests are the first to be performed in order to verify functionality and agreement with specifications presented by the manufacturer.
The longest stage in the process is commissioning, since in this stage all the necessary parameters for the characterization of the treatment machines are inserted into the TPS and tests of functionality and calculation are performed. Commissioning can be divided into dosimetric tests, which aim to compare the performance of the dose calculations generated by the TPS with the experimentally measured doses; nondosimetric tests, which verify the functionality of the tools of TPS; the qualitative planning process; the intercommunication of the TPS with the treatment machine and the devices of image acquisition; and calculation of MU tests, which verify the agreement between the manual calculations of MU and MU generated by TPS.
Periodic tests aim at verifying the reproducibility of planning in accordance with that established in commissioning and its frequency depends on the needs of each radiotherapy department. Patient specific quality assurance aims at verifying the treatment process as a whole.
Although a lot of information is provided in most reports on QA of TPS, 14, 15 it is difficult for a user to decide which tests are absolutely necessary to be carried out by an individual user, and which tests the vendor or users' groups of a specific system should perform. In addition, the number of tests provided by some of those reports is so overwhelming that to perform them would require a very large investment in manpower.
A consensus among national and international documents shows that there is a need for a minimum number of tests. A smaller set of tests is not only suitable to small hospitals with limited resources, but is also needed by large centers that have a high patient load or limited staff.
The vendor should provide the results of the commissioning tests, together with agreed acceptance data, either prior to or immediately after installation of the system. In addition, the vendor should present a list of commissioning/acceptance tests, cross-referenced to acceptance data, that the user should perform on his own. After a reasonable time period, negotiable based on circumstances but before first clinical use, the vendor and user should discuss the results of the tests and decide about complete, or maybe partial, acceptance of the system. In this way on-site participation of the vendor during the acceptance-testing phase can be minimized.
The main aim of the present investigation is to perform the test package as proposed by IAEA TRS 430 13 and to compare it to similar protocols, such as AAPM Task Group 53. 12 The treatment planning system analyzed, Eclipse™ from Varian, is already installed in several radiotherapy departments in Brazil, which motivated the work performed at Sao Paulo University School of Medicine Clinicas Hospital. Based on the results and experience acquired for this specific TPS, a suggestion is made on how to perform the commissioning with less work.
II. MATERIALS AND METHODS
The IAEA recommendations 13 for photon beams were implemented for the Varian Eclipse™ 7.3.10 TPS that serves two Varian linear accelerators ͑Clinac 600C and Clinac 2100C͒ upon its installation at Clinicas Hospital.
The acceptance tests verify the functionality of the system hardware and software components as well as its agreement with the specifications supplied by the manufacturer. For hardware verification, tests address: CPU memory and the operation of the DAT tape ͑digital back-up tape͒, the digitizer table, keyboard, mouse, printer, image displays, hardware backup, and the compatibility between magnetic resonance and tomography image data and the TPS.
For software, the tests verify the correct inset of the anatomical data and the general capabilities that characterize the system. The performance of complementary software, network connections and the data transfer from the TPS to the treatment machine are also verified.
As far as acceptance tests are concerned, the following items were verified: hardware ͑with tests of memory of CPU͒, digitizer table, compatibility between data image ͑CT, MRI͒ and the TPS, keyboard, mouse, printer, DRR and accessories display, storage and backup; integration of network system which includes connections, DICOM format; data transfer, manual, network and/or printer; software, considering data entries of the TC ͑tomography computerized͒ and anatomical description as well as beam description, photon dose calculation; and finally, the complimentary softwares, thus verifying storage of patient information, backup, and printer software.
For the nondosimetric tests, several checklists must be prepared and performed in order to obtain the pertinent parameters. Such lists are developed for verifying the capabilities and the system calculation tools. For this purpose, the following tests were performed: patient information acquisition, insert or transfer of anatomical data, patient anatomical model, beam commissioning, and machine capacity characterization.
The dosimetric tests aim at comparing the values of the dose experimentally determined and the dose generated by TPS. For these tests, standard and nonreference conditions measurements for both accelerators were performed. The measurements were made using a 30ϫ 30ϫ 30 cm 3 water phantom, adapted from Standard Imaging, 16 and a Victoreen Farmer 0.6 cm 3 ionization chamber, calibrated in terms of absorbed dose in water by the Laboratory of Instruments Calibration of the IPEN. The applied dose rate was 320 MU/ min, with a total dose of 50 MU, and the reading was made with an Inovision electrometer, model 35040.
Absolute dose measurement was performed for each of several experimental settings, at two depths for three field sizes, i.e., maximum, minimum, and intermediate, three offaxis distances, and wedge fields with maximum angle. Dose measurements were also made for three gantry angles, four complex field forms, fields with scattering losses, and in the buildup region.
Detailed descriptions of test cases can be found elsewhere ͑TG 53 and TRS 430͒. 12, 13 The influence of basic parameters such as collimator aperture, source-surface distance ͑SSD͒, beam modifiers, and oblique incidence direction are evaluated one by one, according to TRS 430. 13 The description of the dosimetric tests performed in the present work is shown in Table I .
All data were expressed in terms of dose ͑in cGy͒, for an irradiation of 50 MU, including the effects of field size, tray, wedge, and off-axis ratio on the output. A practical procedure for the verification of dose is to determine the absorbed dose in the reference geometry prior to that at points of interest. This is also a check of the stability of the treatment unit during the measurement session ͑Mijnheer et al.͒.
14 In the present work an absolute dose determination was made at the reference point at 10 cm depth for a 10ϫ 10 cm 2 field size at the beginning of each session. In order to verify if the wedge and ionization chamber were correctly positioned, measurements were made with the wedge in its original position and with the wedge, not the collimator, rotated 180°. There are two main approaches for establishing the criteria of acceptability that must be applied before accepting a treatment planning system for clinical use ͑Venselaar and Welleweerd͒: 17 one based on an analysis of clinical doseresponse curves and the other based on an analysis of the applied algorithms and on studies in which the results of calculations are compared with measured data, 4,18 thus providing a judgment of the performance of state-of-art treatment planning systems. Van Dyk et al. 4 and Mijnheer et al.
14 present an overview of all recommendations that can be found in the literature. The criteria for acceptability proposed by Venselaar et al. 18 thus provides the difference between calculated and measured dose values as a percentage of the dose measured locally as follows:
͑1͒
Such normalization determines the success of a radiation tumor treatment and is consequently more clinically relevant. These criteria are related to uncertainties that are unavoidably existent in dose measurements and to errors that result from expected inadequacies of dose calculation model or from its implementation in the treatment planning system.
To avoid the presentation of all data in the form of a large number of histograms, the concept of the confidence limit ⌬ has been used. 17, 18 The confidence limit is based on the calculation of the average deviation between calculated and measured dose values for a group of data points in similar situations and the standard deviation ͑SD͒ of the differences, according to
͑2͒
In order to choose an adequate number of data points to obtain statistically relevant conclusions, data of different field sizes and different beam qualities have been combined. Only representative points were included in this investigation, which means only points well within the beam; points in the buildup and penumbra regions were excluded. A 95% interval confidence level was adopted in the present investigation, corresponding to a standard deviation multiplicative factor of 1.96, since the factor 1.5 was chosen arbitrarily by Venselaar et al. 18 In this way, the confidence limit thus obtained is compared with the acceptability criteria established by IAEA 13 and AAPM Task Goup 53, 12 as well as by Venselaar et al. 18 However, according to AAPM Task Group 53, 12 these criteria are only an example of the kind of variation in dose calculation agreement with measurements that might be expected for a sophisticated algorithm, i.e., they are not to be used as goals or requirements for any specific situation. In this sense, the medical physicist in each institution must evaluate the expectations for each situation and choose the criteria to be applied to the particular beam and algorithm. The clinical needs, dose calculation algorithms, treatment machines, and treatment techniques should be evaluating taking into account the existing conditions of the clinic. The physicist may then modify the recommended limits in order to fit the situation. For the commissioning dosimetric tests, the analysis of results in accordance with TRS 430 13 must be performed through the percent difference ͑␦͒ between the values of dose measured and the doses generated by TPS. These percent differences must be submitted to the tolerance levels following the recommendations of the IAEA document for the regions of the radiation beam and field geometries. 
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According to TRS 430, 13 the ideal compatibility between the experimental dose values and the values generated by a TPS is obtained when 95% of the percent results differences for each beam region and field geometry are within the tolerance levels shown in Table II . However, the IAEA document itself foresees that it is necessary to perform a considerable number of measurements for several field sizes and several depths to obtain such compatibility. As this is not always possible in clinical practice, a more flexible criterion was chosen, where the compatibility between the data was established in accordance with the beam regions, field geometry, and proximity of the percent difference values to the tolerance levels, as given in Table II .
For the calculations of MU tests, the values of MU generated by the TPS must be compared with the values of MU manually calculated. The analysis of the results must also be made using a percent difference between the values; for these tests TRS 430 13 recommends that the percent difference value must be ␦ ഛ ± 2% for reference situations, squared fields and rectangular fields in the central ray and ␦ ഛ ± 3% for fields with beam modifiers and conformational beams. The frequency of periodic quality assurance tests must be established and the guidelines for patient specific quality assurance tests must be detailed, according to the need of using the TPS at hospital.
III. RESULTS AND DISCUSSION
The IAEA document was rigorously followed in the elaboration of this quality assurance program, although in some situations the tests described in the document, had to be adapted to the reality of the hospital. For instance, since the dimensions of the water phantom employed in this work was 30ϫ 30ϫ 30 cm 3 , field sizes were limited to 26 ϫ 26 cm 2 and the maximum depth to 20 cm. The same principle was applied to the choice of the minimum field size in the linear accelerator: a minimum field size of 5 ϫ 5 cm 2 was chosen in order to cover the entire sensible ion chamber volume of 0.6 cm 3 . The implementation plan also followed the order suggested in the protocol; thus, the acceptance tests were performed at the moment of the installation of the system, followed by the commissioning and then by the stipulation of the frequencies of the periodic quality assurance tests necessary to maintaining the reproducibility of the results obtained during commissioning. Lastly, the individual patient control guidelines were enunciated. The results are presented in that order.
A. Acceptance tests
Concerning the acceptance tests, functionality and agreement with manufacturer specifications were verified for the TPS hardware and software: it is possible to see that the Eclipse TPS presented excellent results for the acceptance tests, with all the parameters complying to manufacturer specifications.
B. Commissioning tests

Nondosimetric commissioning tests
For the nondosimetric tests, several TRS 430 13 checklists were completed and pertinent parameters verified. The lists were elaborated to confirm the capabilities as well as the calculation tools of the treatment planning system. From the results thus obtained it was possible to verify that the Eclipse™ TPS satisfactorily performed its tasks and that all the image manipulation and calculation tools functioned within acceptability standards and in accordance with manufacturer specifications.
Results of such tests made it possible to show that the Eclipse TPS in question does not allow procedures that contain physical inconsistencies to be processed. In these cases, the Eclipse™ TPS shows an error message and it does not allow the treatment planning process to be continued.
Dosimetric commissioning tests
For the dosimetric commissioning tests, standard measurements and those in nonreference conditions were used to verify the performance and limitations of the systems algorithm. Figures 1-4 fields, hard wedges, and buildup region behavior. Table III presents all the dosimetric tests results for the 6 MV beams of Clinac 600C, 6 MV of Clinac 2100C, and 15 MV of Clinac 2100C, giving the confidence limit and the acceptability criteria proposed by IAEA, 13 AAPM, 12 and Venselaar et al. 18 One observes that for most of the tests the confidence limits obtained by applying VenselaarЈs methodology are within the acceptability criteria as proposed by IAEA, 13 12 recommendations in more restrictive dosimetric tests, limited to monitor unit calculation accuracy, isodose constancy, and clinical case evaluation, although the latter was only mentioned, without the presentation of results obtained.
Through the dosimetric tests it was possible to evidence that the Eclipse™ satisfactorily performed the dose calculation for various planning situations.The most critical differences occurred for oblique incidence, oblique incidence offaxis, shaped fields, and off-axis wedged. It should be pointed out that the algorithm used in this version of Eclipse™ is the pencil beam convolution. For these cases a detailed study using a larger measurement sample and a more detailed statistical analysis is needed. Moreover, it is necessary that the unit responsible for planning performs a more careful monitoring in clinical situations resembling those types of geometry.
According to IAEA ͑2004͒ 15 a Consultants' Meeting was established in order to create a set of simple and practical acceptance and commissioning tests, defined in a more specific protocol, which can be easily followed at the hospital level. The existing protocols, such as TRS 430, 13 TG53, 12 and ESTRO, 14 due to their completeness and complexity, might therefore make it difficult for a user to choose those tests that are more urgently needed for the situation in a particular institution. Such document, which will be published in 2007, 15 will thus describe a minimum number of benchmark cases, which can be carried out in a reasonable time by a user in a hospital. Additionally, it will also provide separate sets of tests for quality assurance of dosimetry calculations in radiotherapy to be performed by the vendor and by the user.
Based on our results we suggest to reduce the number of dosimetric tests to basically five tests; namely, oblique incidence, oblique incidence off-axis, asymmetric open fields, shaped fields, and off-axis wedged as given by Table IV ͑tests 4, 5, 6, 8, and 10 from Table I͒. For IMRT it would be necessary to perform some tests of MLC-shaped fields because they are used in 3D conformal radiotherapy. 13, 14 According to ESTRO, 14 a large number of tests should be performed by the vendor of a specific system, either before the system is installed in the hospital, or during the acceptance testing at the user's site. Some vendor tests can be generic but their results should be shown to and discussed with the user; others need to be performed at the user's place. Such a division depends on the availability of the user's data to a vendor, as well as the specific situation at a user's location; e.g., of the time and resources available for extensive on site testing.
A pilot study of the IAEA protocol was performed by participants of the IAEA coordinated research project on "Development of procedures for quality assurance for dosimetry calculation in radiotherapy." 21 In that investigation, clinical tests were made in order to facilitate the commissioning process of treatment planning system. The tests cover basic treatment techniques in typical radiotherapy installations and were based on the use of CIRS torso phantom. The authors present the results of 11 hospitals which are using 15 different TPS, given altogether 37 different combinations of algorithms and beam qualities. They found a better agreement for lower energies and more advanced algorithms. The results have demonstrated that proposed test cases ͑ob-lique incidence, irregular field, and blocking the field center͒ can not only ensure the safe use of the TPS in a particular hospital, but may also help the user to appreciate the possibilities of their system and understand its limitations. Additionally, the set of tests for clinical commissioning can be performed in reasonable time in most hospitals, especially in those with limited resources. The criteria shown are based on the collective expectations of the members of the task group and are not to be used as goals or requirements for any particular situation.
MU calculation tests
The tests that compared the values of manually calculated MU and values of TPS generated MU showed about 2% of percent difference for fields with simple geometries. For fields that contained beam modifiers and conformational fields the calculations presented values of percent difference varying from 2% to 3%. Thus, in both situations, the percent differences were within the levels of tolerance suggested by TRS 430. 13 The Eclipse™ presented excellent trustworthiness concerning MU calculations.
It is important to emphasize that the first calculations performed for fields with accessories presented percent differences varying from 4% to 6%, a considerable disagreement. The response of the manufacturer's representative to the hospital contact revealed that the tray factor was not configured to be used in the calculations. After the necessary corrections, the tests were repeated and the percent differences were within tolerance levels. This incident shows the importance of this type of test to confirm that the Eclipse TPS™ is correctly functioning and securely using all configurations and tools.
C. Periodic quality assurance control tests
The periodic quality assurance control tests aim at preserving the observed performance of the system in the acceptance tests and commissioning. In order to achieve this, the following aspects were defined: objective, development procedure, and frequency of each test. The tests suggested for periodic quality assurance control are presented in Table V, in accordance with TRS 430. 13 The frequencies were stipulated in accordance with the use of the TPS by the Clinicas Hospital Radiotherapy Department. To reduce the time spent in the periodic QA we suggest that the control of hardware could be done in a real patient planned in 2-D and that of the anatomical information in a real patient planned in 3-D. The tests for the software may be done repeating weekly the same very complex planning, involving every type of field ͑isocen-tric, SSD, wedge, arc, asymmetric, etc.͒ and observing very carefully the results presented. While these tests will not ensure perfect accuracy or reproducibility for all situations, they are intended to provide a high level of reliability for today's TPS. Since the program must be practicle, it must be structured in such a way that the risk of a serious error in patient dose is minimized, but not be so elaborate that it demands an unrealistic commitment on resources and time. Additionally, a systematic second independent dose calculation is an important control since it is a mean of verification for all treatments.
D. Patient specific quality assurance tests
The verification of the individual patient planning has the aim of determining the consistency during planning and of checking the MU/time relation, as well as manipulation of the patient's specific data. These are daily pretreatment verifications but any unusual behavior must also be monitored during the course of treatment. To confirm that the treatment is being properly performed, it is suggested that in vivo and in vitro dosimetry checks are made with the frequency 22 the combination of a separate check of MU calculations for all patients in combination with in vivo dosimetry for a representative subgroup ͑10% of patients͒ is an effective method for quality assurance.
IV. Conclusions
The implementation of a quality assurance program based on the most recent IAEA document, TRS 430, 13 using Varian Eclipse™ 7.3.10 at the Clinicas Hospital was successfully performed. Practically all the acceptance and commissioning tests were conducted before the system started its clinical use. This treatment planning system presented all capabilities in accordance with specifications, and all limitations were verified and registered. No evidence of risky operations and physical inconsistencies was found during this investigation.
For acceptance tests and nondosimetric commissioning tests, good agreement with the manufacturer's was verified. Therefore, it was possible to confirm the good performance of the Eclipse™ in the calculation of absolute doses and it was also possible to identify the more delicate planning situations that require greater caution by the responsible treatment planning team.
For MU calculation tests results also revealed to be satisfactory; all comparisons between TPS generated calculations and manually calculated values presented percent differences within the tolerance levels recommended by TRS 430. 13 The periodic quality assurance control tests were defined in accordance with TRS 430 13 and the frequencies defined in accordance with the needs of the Clinicas Hospital. Guidelines for individual patient quality assurance were developed. Since the confidence limits obtained for the dosimetric tests were much smaller than acceptability criteria with simple configurations, the quality assurance program presented in this work stated that it is possible to reduce the number of tests without loosing in assurance. Therefore, it is suggested that programs of this type be implemented for every treatment planning systems, in a reduced form of TRS 430. 13 However, larger differences were found for the tests cases of oblique incidence, oblique incidence off-axis, shaped fields and off-axis wedged in accordance with recent results presented by the IAEA 21 pilot study. Better agreement was also obtained with lower energies. For such reasons, we thus recommend a limited number of tests, namely, oblique incidence, oblique incidence off-axis, asymmetric open fields, shaped fields, and off-axis wedged in order to evaluate the performance of a particular TPS and that the recent recommendations from IAEA 15 and ESTRO 14 to manufactures and users for sharing their experience in the acceptance and commissioning in a given TPS are adopted. As stated by 23 for the more recent 3-D treatment planning systems, the open field tests are becoming less relevant to current radiotherapy practice than others. On the other hand, it is extremely important that algorithms correctly predict the dose for open fields due to the fact that the TPS should not be trusted for more complex fields if it fails the basic tests.
The staff experience with implementing the quality assurance program for a commercial TPS is extremely useful as part of training, especially when a new planning system is acquired by the hospital. The existing test packages, such as IAEA TRS 430, 13 AAPM TG53, 12 and ESTRO, 14 provide means of verification of all steps involved in a treatment planning system, ranging from the acceptance tests to the dosimetric tests. Furthermore, particular attention should be addressed to dosimetric tests with more complex geometries ͑oblique incidence, oblique incidence off-axis, shaped fields, and wedges off-axis͒. The IAEA TRS 430 13 is a more comprehensive document that includes the most recent technical developments, such as asymmetrical and multileaf collimators. Detailed information on the performance of the dosimetric tests should provide important points for discussion in a users meeting.
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